Were state and federal courts to defer sufficiently to FDA determinations of drug safety, the...
Contributor Information
Daniel E. Troy
Managing Director, Berkeley Research Group
Biography
Dan Troy is Managing Director and an expert witness on FDA matters at Berkeley Research Group. Previously he served as Chief Counsel of the US Food and Drug Administration and General Counsel of GlaxoSmithKline PLC.
FDA Labeling and State Liability
Daniel E. Troy
Were state and federal courts to defer sufficiently to FDA determinations of drug safety, the...